{"entity":{"type":"insider","cik":"0001331852","url":"/insider/0001331852","json_url":"/insider/0001331852.json","name":"Zakrzewski Joseph S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":68,"n_filings":42,"first":"2008-07-01","last":"2024-11-27","span_basis":"filed_date"},"name_variants":[{"name":"Zakrzewski Joseph S","source":"filing","n_filings":42,"first_seen":"2008-07-01","last_seen":"2024-11-27"}],"transactions":[{"id":3113303,"accession":"0000950170-24-131499","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-131499","line_url":"/filing/0000950170-24-131499#line-1","is_derivative":false,"issuer_cik":"0001331852","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001331852","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.4,"price_display":"1.40","price_state":"stated","total_value":2800.0,"total_display":"2,800.00","total_whole":"2,800","shares_owned_after":125199.0,"shares_owned_after_display":"125,199","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-27","filed_date":"2024-11-27","scope":"insider"},{"id":2773837,"accession":"0000950170-24-129248","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-129248","line_url":"/filing/0000950170-24-129248#line-2","is_derivative":false,"issuer_cik":"0001331852","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001331852","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":5050.0,"total_display":"5,050.00","total_whole":"5,050","shares_owned_after":123199.0,"shares_owned_after_display":"123,199","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-19","filed_date":"2024-11-20","scope":"insider"},{"id":2773828,"accession":"0000950170-24-129248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-129248","line_url":"/filing/0000950170-24-129248#line-1","is_derivative":false,"issuer_cik":"0001331852","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001331852","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.9998,"price_display":"1.00","price_state":"stated","total_value":19996.0,"total_display":"19,996.00","total_whole":"19,996","shares_owned_after":118199.0,"shares_owned_after_display":"118,199","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-20","scope":"insider"},{"id":2982625,"accession":"0000950170-24-005900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-005900","line_url":"/filing/0000950170-24-005900#line-1","is_derivative":false,"issuer_cik":"0001331852","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001331852","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":19.1141,"price_display":"19.11","price_state":"stated","total_value":1911410.0,"total_display":"1,911,410.00","total_whole":"1,911,410","shares_owned_after":405880.0,"shares_owned_after_display":"405,880","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-18","filed_date":"2024-01-19","scope":"insider"},{"id":6575288,"accession":"0001209191-22-060377","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-060377","line_url":"/filing/0001209191-22-060377#line-1","is_derivative":false,"issuer_cik":"0001331852","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001331852","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21202.0,"shares_display":"21,202","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":27562.6,"total_display":"27,562.60","total_whole":"27,563","shares_owned_after":154618.0,"shares_owned_after_display":"154,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-07","filed_date":"2022-12-08","scope":"insider"},{"id":6698775,"accession":"0001209191-22-029135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-029135","line_url":"/filing/0001209191-22-029135#line-1","is_derivative":false,"issuer_cik":"0001331852","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001331852","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":743.0,"shares_display":"743","price_per_share":1.61,"price_display":"1.61","price_state":"stated","total_value":1196.23,"total_display":"1,196.23","total_whole":"1,196","shares_owned_after":133416.0,"shares_owned_after_display":"133,416","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-16","scope":"insider"},{"id":6329631,"accession":"0001209191-22-028574","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-028574","line_url":"/filing/0001209191-22-028574#line-2","is_derivative":false,"issuer_cik":"0001331852","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001331852","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":1700.0,"total_display":"1,700.00","total_whole":"1,700","shares_owned_after":132673.0,"shares_owned_after_display":"132,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-11","filed_date":"2022-05-12","scope":"insider"},{"id":6329629,"accession":"0001209191-22-028574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-028574","line_url":"/filing/0001209191-22-028574#line-1","is_derivative":false,"issuer_cik":"0001331852","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001331852","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49406.0,"shares_display":"49,406","price_per_share":1.89,"price_display":"1.89","price_state":"stated","total_value":93377.34,"total_display":"93,377.34","total_whole":"93,377","shares_owned_after":131673.0,"shares_owned_after_display":"131,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-10","filed_date":"2022-05-12","scope":"insider"},{"id":4088860,"accession":"0000899243-21-049973","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-049973","line_url":"/filing/0000899243-21-049973#line-4","is_derivative":false,"issuer_cik":"0001331852","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001331852","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":601.0,"shares_display":"601","price_per_share":9.85,"price_display":"9.85","price_state":"stated","total_value":5919.85,"total_display":"5,919.85","total_whole":"5,920","shares_owned_after":82267.0,"shares_owned_after_display":"82,267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-28","filed_date":"2021-12-28","scope":"insider"},{"id":4088857,"accession":"0000899243-21-049973","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-049973","line_url":"/filing/0000899243-21-049973","is_derivative":false,"issuer_cik":"0001331852","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001331852","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":299.0,"shares_display":"299","price_per_share":10.03953177257525,"price_display":"10.04","price_state":"stated","total_value":3001.82,"total_display":"3,001.82","total_whole":"3,002","shares_owned_after":81567.0,"shares_owned_after_display":"81,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-27","filed_date":"2021-12-28","scope":"insider","n_lines":2},{"id":4088849,"accession":"0000899243-21-049973","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-049973","line_url":"/filing/0000899243-21-049973#line-1","is_derivative":false,"issuer_cik":"0001331852","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001331852","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":9.87,"price_display":"9.87","price_state":"stated","total_value":1974.0,"total_display":"1,974.00","total_whole":"1,974","shares_owned_after":81367.0,"shares_owned_after_display":"81,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-28","scope":"insider"},{"id":5195086,"accession":"0000899243-21-049198","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-049198","line_url":"/filing/0000899243-21-049198#line-1","is_derivative":false,"issuer_cik":"0001331852","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001331852","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":9.88,"price_display":"9.88","price_state":"stated","total_value":1976.0,"total_display":"1,976.00","total_whole":"1,976","shares_owned_after":81167.0,"shares_owned_after_display":"81,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-17","filed_date":"2021-12-21","scope":"insider"},{"id":5456229,"accession":"0000899243-21-048432","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-048432","line_url":"/filing/0000899243-21-048432","is_derivative":false,"issuer_cik":"0001331852","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001331852","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3700.0,"shares_display":"3,700","price_per_share":10.768648648648648,"price_display":"10.77","price_state":"stated","total_value":39844.0,"total_display":"39,844.00","total_whole":"39,844","shares_owned_after":79267.0,"shares_owned_after_display":"79,267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-15","scope":"insider","n_lines":2},{"id":5376676,"accession":"0001562180-21-007737","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-007737","line_url":"/filing/0001562180-21-007737#line-2","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.155,"price_display":"3.16","price_state":"stated","total_value":6310.0,"total_display":"6,310.00","total_whole":"6,310","shares_owned_after":196547.0,"shares_owned_after_display":"196,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-16","scope":"insider"},{"id":5376674,"accession":"0001562180-21-007737","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-007737","line_url":"/filing/0001562180-21-007737#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.2689,"price_display":"3.27","price_state":"stated","total_value":32689.0,"total_display":"32,689.00","total_whole":"32,689","shares_owned_after":194547.0,"shares_owned_after_display":"194,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-14","filed_date":"2021-12-16","scope":"insider"},{"id":4519947,"accession":"0001179110-21-004227","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-21-004227","line_url":"/filing/0001179110-21-004227","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":140.734344,"price_display":"140.73","price_state":"stated","total_value":1407343.44,"total_display":"1,407,343.44","total_whole":"1,407,343","shares_owned_after":37751.0,"shares_owned_after_display":"37,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-05","scope":"insider","n_lines":3},{"id":4295600,"accession":"0001179110-21-004122","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-21-004122","line_url":"/filing/0001179110-21-004122","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":134.638236,"price_display":"134.64","price_state":"stated","total_value":1346382.36,"total_display":"1,346,382.36","total_whole":"1,346,382","shares_owned_after":37799.0,"shares_owned_after_display":"37,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-02","scope":"insider","n_lines":4},{"id":3312039,"accession":"0001209191-20-020303","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-020303","line_url":"/filing/0001209191-20-020303#line-1","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.99,"price_display":"4.99","price_state":"stated","total_value":24950.0,"total_display":"24,950.00","total_whole":"24,950","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-19","scope":"insider"},{"id":3039657,"accession":"0001209191-20-019005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-019005","line_url":"/filing/0001209191-20-019005#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.67,"price_display":"5.67","price_state":"stated","total_value":28350.0,"total_display":"28,350.00","total_whole":"28,350","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-13","filed_date":"2020-03-13","scope":"insider"},{"id":3039653,"accession":"0001209191-20-019005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-019005","line_url":"/filing/0001209191-20-019005#line-1","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":6.31,"price_display":"6.31","price_state":"stated","total_value":94650.0,"total_display":"94,650.00","total_whole":"94,650","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-12","filed_date":"2020-03-13","scope":"insider"},{"id":3337839,"accession":"0001209191-20-001469","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-001469","line_url":"/filing/0001209191-20-001469#line-2","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":20.9429,"price_display":"20.94","price_state":"stated","total_value":6282870.0,"total_display":"6,282,870.00","total_whole":"6,282,870","shares_owned_after":84547.0,"shares_owned_after_display":"84,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-03","filed_date":"2020-01-03","scope":"insider"},{"id":8601834,"accession":"0001209191-19-061213","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-061213","line_url":"/filing/0001209191-19-061213#line-2","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":25.8338,"price_display":"25.83","price_state":"stated","total_value":2583380.0,"total_display":"2,583,380.00","total_whole":"2,583,380","shares_owned_after":84547.0,"shares_owned_after_display":"84,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-16","filed_date":"2019-12-18","scope":"insider"},{"id":8702359,"accession":"0001209191-19-041364","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-041364","line_url":"/filing/0001209191-19-041364#line-2","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":23.8158,"price_display":"23.82","price_state":"stated","total_value":2381580.0,"total_display":"2,381,580.00","total_whole":"2,381,580","shares_owned_after":84547.0,"shares_owned_after_display":"84,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-05","filed_date":"2019-07-05","scope":"insider"},{"id":8319186,"accession":"0001209191-19-038330","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-038330","line_url":"/filing/0001209191-19-038330#line-2","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":19.0209,"price_display":"19.02","price_state":"stated","total_value":1902090.0,"total_display":"1,902,090.00","total_whole":"1,902,090","shares_owned_after":84547.0,"shares_owned_after_display":"84,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-18","filed_date":"2019-06-20","scope":"insider"},{"id":7906599,"accession":"0001179110-19-007787","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-19-007787","line_url":"/filing/0001179110-19-007787#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":38.05,"price_display":"38.05","price_state":"stated","total_value":190250.0,"total_display":"190,250.00","total_whole":"190,250","shares_owned_after":12750.0,"shares_owned_after_display":"12,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-14","filed_date":"2019-06-17","scope":"insider"},{"id":8098551,"accession":"0001209191-19-012808","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-012808","line_url":"/filing/0001209191-19-012808#line-3","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":180625.0,"shares_display":"180,625","price_per_share":19.9,"price_display":"19.90","price_state":"stated","total_value":3594437.5,"total_display":"3,594,437.50","total_whole":"3,594,438","shares_owned_after":84547.0,"shares_owned_after_display":"84,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-22","filed_date":"2019-02-22","scope":"insider"},{"id":8311119,"accession":"0001209191-19-003500","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-003500","line_url":"/filing/0001209191-19-003500","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":16.98195,"price_display":"16.98","price_state":"stated","total_value":3396390.0,"total_display":"3,396,390.00","total_whole":"3,396,390","shares_owned_after":84547.0,"shares_owned_after_display":"84,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-10","filed_date":"2019-01-11","scope":"insider","n_lines":2},{"id":8341811,"accession":"0001209191-19-000522","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-000522","line_url":"/filing/0001209191-19-000522#line-4","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":385000.0,"shares_display":"385,000","price_per_share":13.0278,"price_display":"13.03","price_state":"stated","total_value":5015703.0,"total_display":"5,015,703.00","total_whole":"5,015,703","shares_owned_after":84547.0,"shares_owned_after_display":"84,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-02","scope":"insider"},{"id":8341797,"accession":"0001209191-19-000522","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-000522","line_url":"/filing/0001209191-19-000522#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":141500.0,"shares_display":"141,500","price_per_share":13.192,"price_display":"13.19","price_state":"stated","total_value":1866668.0,"total_display":"1,866,668.00","total_whole":"1,866,668","shares_owned_after":84547.0,"shares_owned_after_display":"84,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-28","filed_date":"2019-01-02","scope":"insider"},{"id":6608883,"accession":"0001209191-18-052390","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-052390","line_url":"/filing/0001209191-18-052390","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":10.5986671502,"price_display":"10.60","price_state":"stated","total_value":5299333.5751,"total_display":"5,299,333.58","total_whole":"5,299,334","shares_owned_after":318796.0,"shares_owned_after_display":"318,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-24","filed_date":"2018-09-26","scope":"insider","n_lines":3},{"id":4185514,"accession":"0001127602-17-010311","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001127602-17-010311","line_url":"/filing/0001127602-17-010311","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":46.862364865,"price_display":"46.86","price_state":"stated","total_value":1874494.5946,"total_display":"1,874,494.59","total_whole":"1,874,495","shares_owned_after":27849.0,"shares_owned_after_display":"27,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-02","filed_date":"2017-03-03","scope":"insider","n_lines":3},{"id":4730101,"accession":"0001179110-17-000102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-17-000102","line_url":"/filing/0001179110-17-000102#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":25.5,"price_display":"25.50","price_state":"stated","total_value":102000.0,"total_display":"102,000.00","total_whole":"102,000","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-30","filed_date":"2017-01-03","scope":"insider"},{"id":5294480,"accession":"0001181431-13-059457","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-059457","line_url":"/filing/0001181431-13-059457#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50777.0,"shares_display":"50,777","price_per_share":1.54,"price_display":"1.54","price_state":"stated","total_value":78196.58,"total_display":"78,196.58","total_whole":"78,197","shares_owned_after":226047.0,"shares_owned_after_display":"226,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-18","filed_date":"2013-11-18","scope":"insider"},{"id":2361894,"accession":"0001181431-12-053566","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-053566","line_url":"/filing/0001181431-12-053566#line-2","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":12.5621,"price_display":"12.56","price_state":"stated","total_value":1884315.0,"total_display":"1,884,315.00","total_whole":"1,884,315","shares_owned_after":111937.0,"shares_owned_after_display":"111,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-01","filed_date":"2012-10-03","scope":"insider"},{"id":3340935,"accession":"0001181431-12-042747","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-12-042747","line_url":"/filing/0001181431-12-042747","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":14.3146164,"price_display":"14.31","price_state":"stated","total_value":2147192.46,"total_display":"2,147,192.46","total_whole":"2,147,192","shares_owned_after":111937.0,"shares_owned_after_display":"111,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-27","filed_date":"2012-07-30","scope":"insider","n_lines":2},{"id":2960651,"accession":"0001181431-12-033788","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-033788","line_url":"/filing/0001181431-12-033788#line-2","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":11.9681,"price_display":"11.97","price_state":"stated","total_value":1795215.0,"total_display":"1,795,215.00","total_whole":"1,795,215","shares_owned_after":78604.0,"shares_owned_after_display":"78,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-29","filed_date":"2012-05-31","scope":"insider"},{"id":3438629,"accession":"0001181431-12-019802","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-019802","line_url":"/filing/0001181431-12-019802#line-2","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001331852","owner_name":"Zakrzewski Joseph S","owner_display_name":"Zakrzewski Joseph S","owner_url":"/insider/0001331852","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":160000.0,"shares_display":"160,000","price_per_share":11.591,"price_display":"11.59","price_state":"stated","total_value":1854560.0,"total_display":"1,854,560.00","total_whole":"1,854,560","shares_owned_after":78604.0,"shares_owned_after_display":"78,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-23","filed_date":"2012-03-27","scope":"insider"}],"collapsed":true,"next_cursor":"2012-03-23|3438629","ledger_fault":false,"count":{"value":68,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":34,"open_market":true},{"code":"S","label":"Open-market sale","n":34,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":68},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001880438","name":"AN2 Therapeutics, Inc.","url":"/issuer/0001880438","role":"Director","n_filings":3,"first_seen":"2024-01-19","last_seen":"2024-11-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001662244","name":"Cyteir Therapeutics, Inc.","url":"/issuer/0001662244","role":"Director","n_filings":6,"first_seen":"2021-12-15","last_seen":"2022-12-08"},{"type":"issuer","type_label":"ISSUER","cik":"0000897448","name":"AMARIN CORP PLC\\UK","url":"/issuer/0000897448","role":"Director, Officer (Chief Executive Officer)","n_filings":17,"first_seen":"2011-02-24","last_seen":"2021-12-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001280600","name":"ACCELERON PHARMA INC","url":"/issuer/0001280600","role":"Director","n_filings":4,"first_seen":"2017-01-03","last_seen":"2021-04-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001001233","name":"SANGAMO THERAPEUTICS, INC","url":"/issuer/0001001233","role":"Director","n_filings":2,"first_seen":"2020-03-13","last_seen":"2020-03-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001145197","name":"INSULET CORP","url":"/issuer/0001145197","role":"Director","n_filings":3,"first_seen":"2008-11-13","last_seen":"2017-03-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001066833","name":"DOV PHARMACEUTICAL INC","url":"/issuer/0001066833","role":"Director","n_filings":7,"first_seen":"2008-07-01","last_seen":"2008-11-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001331852","retrieved_at":"2026-08-26T04:58:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}